Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Filings indexed 913 across all filing types
Latest filing 2023-07-23 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C (Replacement) 10 pages 561.6KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 24 July 2023, titled 'Replacement Quarterly Report and Cashflow' for ECS Botanics Holdings Ltd. It provides detailed financial and operational updates for the quarter ending 30 June 2023 (Q4 FY23), including unaudited trading revenue, cash flow figures, and operational highlights. The document includes a full Appendix 4C Quarterly cash flow report, which is a regulatory requirement under ASX Listing Rule 4.7B for quarterly reporting. The content contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an interim or quarterly report. It is not merely an announcement of a report but includes the actual financial statements and operational commentary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2023
2023-07-23 English
Change of Share Registry 1 page 107.0KB
Regulatory Filings Classification · 95% confidence The document is a notification about a change in the company's share registry service provider. It does not contain financial data, management changes, voting results, or any report content. It is an announcement related to shareholder services and registry details. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-07-23 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 532.3KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 10 July 2023 from ECS Botanics Holdings Ltd providing a quarterly update on financial and operational activities for the quarter ending 30 June 2023 (Q4 FY23). It includes unaudited trading revenue, cash flow details, operational highlights, contract wins, and outlook commentary. The document also contains the Appendix 4C quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX to report quarterly cash flows. The content is comprehensive and includes substantive financial data and analysis for the quarter, not just a brief announcement or summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data. It is not merely an announcement of a report or a certification. Therefore, the correct classification is IR with high confidence. Q4 2023
2023-07-09 English
Change of Auditor 1 page 253.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 6 July 2023 regarding a change of auditor for ECS Botanics Holdings Ltd. It announces the appointment of a new auditor following the resignation of the previous auditor and mentions ASIC's consent to the resignation. The document is short (1522 characters) and serves as an announcement rather than a detailed audit report or financial statement. It does not contain financial data or audit results, only the auditor change information. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-07-05 English
ECS secures Australian supply agreements worth $11.9m 2 pages 299.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 26 June 2023 from ECS Botanics Holdings Ltd. It details the securing of two binding offtake agreements worth at least $11.9 million to supply medicinal cannabis dried flower. The content focuses on business agreements and supply contracts rather than financial results, management changes, or regulatory filings. There is no indication of financial statements, earnings data, or report attachments. The document is a corporate announcement about commercial contracts, which fits best under Capital/Financing Update (CAP) as it relates to business development and supply agreements impacting company operations and revenue streams.
2023-06-25 English
Trading Halt 2 pages 706.0KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ECS Botanics Holdings Ltd regarding a trading halt requested pending the release of a material supply agreement announcement. It is dated 23 June 2023 and explicitly states that the trading halt is until the release of the announcement. The document does not contain any financial data, report content, or detailed disclosures but is a regulatory announcement about trading status. The document length is short (2579 characters), and it is clearly an announcement rather than a report or detailed filing. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for general regulatory announcements and compliance notices that do not fit other categories.
2023-06-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.